#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma Acquired haemophilia Systemic lupus erythematosus Advanced systemic mastocytosis Iron overload Sickle cell anaemia Glomerulonephritis chronic Myeloid leukaemia Thalassaemia alpha Sjogren's syndrome Immunodeficiency common variable Synovial sarcoma recurrent Staphylococcal infection Systemic mastocytosis Becker's muscular dystrophy More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis Idiopathic inflammatory myopathy Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Urea cycle disorder – Trials in Disease Nephroblastoma Ocular melanoma – Basic Information Richter’s syndrome Angiosarcoma – Diagnostics Paraneoplastic neurological syndrome – Treatment Adrenocortical carcinoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Relugolix Esmolol Hydrochloride Vincristine Diclofenac Diethylamine Dronedarone Ketoprofen Myrrh Bomedemstat Metformin Embonate Kbp-336 Tofogliflozin Abc-23A-116 Skin Autograft Zofenopril Calcium Poa Pratensis Pollen Extract Ubiquinol Arachis Hypogaea (762) Tadekinig Alfa Tolebrutinib Asciminib Hydrochloride More therapies…

    Learn about Your Condition

    Pseudomonas infection Perineal injury Generalised anxiety disorder Premature rupture of membranes Triple positive breast cancer Malformation venous Thromboangiitis obliterans Low cardiac output syndrome Benign prostatic hyperplasia Stem cell transplant Alveolar proteinosis Acute kidney injury Rectal neoplasm Papulopustular rosacea Notalgia paraesthetica More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Breast cancer

  • A Study Using Indocyanine Green Fluorescence Imaging to Help Surgeons Better Identify Tumor Edges During Cancer Surgery in Patients with Solid Tumors

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Genitourinary tract neoplasm
    • Hepatobiliary cancer
    Investigated Drugs:
    • Indocyanine Green
    The Netherlands

  • Study of 6qc-ICG applied to the skin during breast cancer surgery to help surgeons see tumor edges in patients having breast conserving operations

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • 6QC-ICG
    The Netherlands

  • A study testing zanidatamab combined with chemotherapy before surgery in patients with HER2-positive breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    • Breast cancer stage II
    • Breast cancer stage III
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Trastuzumab Emtansine
    • Zanidatamab
    Germany Italy Spain

  • Evaluation of Lung Function Using Xenon Gas with CT Imaging in Lung and Breast Cancer Patients Receiving Radiotherapy

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Breast cancer
    Investigated Drugs:
    • XENON (133XE)
    Belgium

  • Study of tamoxifen loading dose and Ki67 response in breast cancer patients before surgery (ENDO-67)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Tamoxifen
    The Netherlands

  • Study on Everolimus and Exemestane for Patients with Metastatic Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 negative breast cancer
    • Breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Exemestane
    • Everolimus
    Hungary
Previous Page
1 … 12 13 14 15 16 … 28
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!